Literature DB >> 17405796

Phosphorylation of the C-terminal domain of RNA polymerase II plays central roles in the integrated events of eucaryotic gene expression.

Yutaka Hirose1, Yoshiaki Ohkuma.   

Abstract

RNA polymerase II (Pol II) is the only polymerase to possess heptapeptide repeats in the C-terminal domain (CTD) of its large subunit. During transcription, CTD phopshorylation occurs and is maintained from initiation to termination. To date, among the three known CTD kinases possessing CDK-cyclin pairs, TFIIH is the only one that forms a preinitiation complex. The Mediator complex plays essential roles in transcription initiation and during the transition from initiation to elongation by transmitting signals from transcriptional activators to Pol II. P-TEFb specifically plays a role in transcription elongation. TFIIH and mediator phosphorylate serine 5 (Ser5) of the CTD heptapeptide repeat sequence, whereas P-TEFb phosphorylates serine 2 (Ser2). Recently, it has become clear that CTD phosphorylation is not only essential for transcription, but also as a platform for RNA processing and chromatin regulation. In this review, we discuss the central role of Pol II phosphorylation in these nuclear events.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17405796     DOI: 10.1093/jb/mvm090

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  70 in total

Review 1.  Transcriptional activators and activation mechanisms.

Authors:  Jun Ma
Journal:  Protein Cell       Date:  2011-12-17       Impact factor: 14.870

2.  Xenopus Nanos1 is required to prevent endoderm gene expression and apoptosis in primordial germ cells.

Authors:  Fangfang Lai; Amar Singh; Mary Lou King
Journal:  Development       Date:  2012-03-07       Impact factor: 6.868

3.  Multiple roles for the Ess1 prolyl isomerase in the RNA polymerase II transcription cycle.

Authors:  Zhuo Ma; David Atencio; Cassandra Barnes; Holland DeFiglio; Steven D Hanes
Journal:  Mol Cell Biol       Date:  2012-07-09       Impact factor: 4.272

4.  Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation.

Authors:  Shaoyong Chen; Sarah Gulla; Changmeng Cai; Steven P Balk
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

5.  Aberrant histone modifications at the thyrotropin-releasing hormone gene in resistance to thyroid hormone: analysis of F455S mutant thyroid hormone receptor.

Authors:  Ryohei Umezawa; Masanobu Yamada; Kazuhiko Horiguchi; Sumiyasu Ishii; Koshi Hashimoto; Shuichi Okada; Teturou Satoh; Masatomo Mori
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

6.  Drosophila suppressor of sable protein [Su(s)] promotes degradation of aberrant and transposon-derived RNAs.

Authors:  Yung-Shu Kuan; Paul Brewer-Jensen; Wen-Li Bai; Cedric Hunter; Carrie B Wilson; Sarah Bass; John Abernethy; James S Wing; Lillie L Searles
Journal:  Mol Cell Biol       Date:  2009-08-17       Impact factor: 4.272

7.  Smicl is required for phosphorylation of RNA polymerase II and affects 3'-end processing of RNA at the midblastula transition in Xenopus.

Authors:  Clara Collart; Joana M Ramis; Thomas A Down; James C Smith
Journal:  Development       Date:  2009-10       Impact factor: 6.868

8.  CpG-island promoters drive transcription of human telomeres.

Authors:  Solomon G Nergadze; Benjamin O Farnung; Harry Wischnewski; Lela Khoriauli; Valerio Vitelli; Raghav Chawla; Elena Giulotto; Claus M Azzalin
Journal:  RNA       Date:  2009-10-22       Impact factor: 4.942

9.  Gld2 activity is regulated by phosphorylation in the N-terminal domain.

Authors:  Christina Z Chung; Nileeka Balasuriya; Emad Manni; Xuguang Liu; Shawn Shun-Cheng Li; Patrick O'Donoghue; Ilka U Heinemann
Journal:  RNA Biol       Date:  2019-05-05       Impact factor: 4.652

10.  FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2.

Authors:  Jacob C Schwartz; Christopher C Ebmeier; Elaine R Podell; Joseph Heimiller; Dylan J Taatjes; Thomas R Cech
Journal:  Genes Dev       Date:  2012-12-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.